Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018 (2018), Article ID 3826989, 8 pages
https://doi.org/10.1155/2018/3826989
Research Article

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

1Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, R Weigl 12, 53-114 Wroclaw, Poland
2Urology and Urologic Oncology Department, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland
3Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dabrowskiego 25, 40-032 Katowice, Poland

Correspondence should be addressed to Lidia Karabon

Received 23 August 2017; Accepted 14 November 2017; Published 7 February 2018

Academic Editor: Nejat K. Egilmez

Copyright © 2018 Lidia Karabon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. M. Ferrara, “Advances in the clinical management of GVHD,” Best Practice & Research Clinical Haematology, vol. 21, no. 4, pp. 677–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. H. Wiseman, “Donor cell leukemia: a review,” Biology of Blood and Marrow Transplantation, vol. 17, no. 6, pp. 771–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. Frauwirth and C. B. Thompson, “Activation and inhibition of lymphocytes by costimulation,” The Journal of Clinical Investigation, vol. 109, no. 3, pp. 295–299, 2002. View at Publisher · View at Google Scholar
  4. T. L. Walunas, C. Y. Bakker, and J. A. Bluestone, “CTLA-4 ligation blocks CD28-dependent T cell activation,” Journal of Experimental Medicine, vol. 183, no. 6, pp. 2541–2550, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Gorgi, I. Sfar, T. B. Abdallah et al., “Ctla-4 exon 1 (+49) and promoter (−318) gene polymorphisms in kidney transplantation,” Transplantation Proceedings, vol. 38, no. 7, pp. 2303–2305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Wiśniewski, M. Kusztal, M. Magott-Procelewska et al., “Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant,” Transplantation Proceedings, vol. 38, no. 1, pp. 56–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. de Reuver, V. Pravica, W. Hop et al., “Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation,” American Journal of Transplantation, vol. 3, no. 12, pp. 1587–1594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Krichen, I. Sfar, R. Bardi et al., “CD86 + 1057G>A polymorphism and susceptibility to acute kidney allograft rejection,” Iranian Journal of Kidney Diseases, vol. 5, no. 3, pp. 187–193, 2011. View at Google Scholar
  9. L. A. Marín, M. R. Moya-Quiles, M. Miras et al., “Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients,” Transplant Immunology, vol. 15, no. 1, pp. 69–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. F.-f. Han, H. Fan, Z.-h. Wang et al., “Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft,” Transplant Immunology, vol. 31, no. 2, pp. 81–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Perez-Garcia, R. De la Camara, J. Roman-Gomez et al., “CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors,” Blood, vol. 110, no. 1, pp. 461–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Azarian, M. Busson, V. Lepage et al., “Donor CTLA-4 +49 A/GGG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations,” Blood, vol. 110, no. 13, pp. 4623-4624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Wu, J. L. Tang, S. J. Wu, H. Y. Lio, and Y. C. Yang, “Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation,” Clinica Chimica Acta, vol. 403, no. 1-2, pp. 229–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Jagasia, W. B. Clark, K. D. Brown-Gentry et al., “Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies,” Biology of Blood and Marrow Transplantation, vol. 18, no. 7, pp. 1069–1075, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. Chien, X. C. Zhang, W. Fan et al., “Evaluation of published single nucleotide polymorphisms associated with acute GVHD,” Blood, vol. 119, no. 22, pp. 5311–5319, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Karabon, M. Markiewicz, A. Partyka et al., “A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation,” Immunogenetics, vol. 67, no. 5-6, pp. 295–304, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Excoffier and M. Slatkin, “Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population,” Molecular Biology and Evolution, vol. 12, no. 5, pp. 921–927, 1995. View at Publisher · View at Google Scholar
  18. A. Svejgaard and L. P. Ryder, “HLA and disease associations: detecting the strongest association,” Tissue Antigens, vol. 43, no. 1, pp. 18–27, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Bosch-Vizcaya, A. Pérez-García, S. Brunet et al., “Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors,” Biology of Blood and Marrow Transplantation, vol. 18, no. 1, pp. 100–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Xiao, Y. Luo, X. Lai et al., “Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies,” Haematologica, vol. 97, no. 12, pp. 1804–1812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Pérez-García, G. Osca, A. Bosch-Vizcaya et al., “Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription,” Human Immunology, vol. 74, no. 9, pp. 1219–1224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. I. Mossallam and M. A. Samra, “CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation,” Human Immunology, vol. 74, no. 12, pp. 1643–1648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Abdallah, E. A. Renzoni, S. Anevlavis et al., “A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis,” International Journal of Immunogenetics, vol. 33, no. 3, pp. 155–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Bossé, M. Lemire, A. H. Poon et al., “Asthma and genes encoding components of the vitamin D pathway,” Respiratory Research, vol. 10, no. 1, p. 98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Lee, E. B. Lee, E. S. Shin et al., “The interaction between allelic variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis,” Allergy, Asthma & Immunology Research, vol. 6, no. 2, pp. 137–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Wagner, M. Sobczyński, L. Karabon et al., “Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset,” Journal of Neuroimmunology, vol. 288, pp. 79–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Delneste, R. Bosotti, G. Magistrelli, J.-Y. Bonnefoy, and J.-F. Gauchat, “Detection of a polymorphism in exon 8 of the human CD86 gene,” Immunogenetics, vol. 51, no. 8-9, pp. 762-763, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Matsushita, N. Tsuchiya, T. Oka, A. Yamane, and K. Tokunaga, “New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus,” Genes & Immunity, vol. 1, no. 7, pp. 428–434, 2000. View at Publisher · View at Google Scholar
  29. H. Xiang, W. Zhao, Y. Sun et al., “CD86 gene variants and susceptibility to pancreatic cancer,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 12, pp. 2061–2067, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Wang, H. Song, J. Liu, B. Song, and X. Cao, “CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma,” DNA and Cell Biology, vol. 30, no. 11, pp. 925–929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. X. M. Pan, L. B. Gao, W. B. Liang et al., “CD86 +1057 G/A polymorphism and the risk of colorectal cancer,” DNA and Cell Biology, vol. 29, no. 7, pp. 381–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Geng, X. Zhao, L. Xiang et al., “Distinct role of CD86 polymorphisms (rs1129055, rs17281995) in risk of cancer: evidence from a meta-analysis,” PLoS One, vol. 9, no. 11, article e109131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Liu, W. B. Liang, L. B. Gao et al., “CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease,” Human Immunology, vol. 71, no. 11, pp. 1141–1146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Eskandari-Nasab, M. Moghadampour, H. Najibi, and M. Hadadi-Fishani, “Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection,” Microbiology and Immunology, vol. 58, no. 2, pp. 135–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Song, L. Tang, M. Xu et al., “CD86 polymorphism affects pneumonia-induced sepsis by decreasing gene expression in monocytes,” Inflammation, vol. 38, no. 2, pp. 879–885, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. W. L. Liao, R. H. Chen, H. J. Lin et al., “The association between polymorphisms of B7 molecules (CD80 and CD86) and Graves’ ophthalmopathy in a Taiwanese population,” Ophthalmology, vol. 118, no. 3, pp. 553–557, 2011. View at Publisher · View at Google Scholar · View at Scopus